BIVEZLA Trademark

Trademark Overview


On Thursday, September 7, 2023, a trademark application was filed for BIVEZLA with the United States Patent and Trademark Office. The USPTO has given the BIVEZLA trademark a serial number of 98168448. The federal status of this trademark filing is REGISTERED as of Tuesday, August 12, 2025. This trademark is owned by Glaxo Group Limited. The BIVEZLA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
bivezla

General Information


Serial Number98168448
Word MarkBIVEZLA
Filing DateThursday, September 7, 2023
Status700 - REGISTERED
Status DateTuesday, August 12, 2025
Registration Number7886128
Registration DateTuesday, August 12, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Monday, September 11, 2023NEW APPLICATION ENTERED
Friday, September 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2024ASSIGNED TO EXAMINER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 12, 2024TEAS DELETE 1(B) BASIS RECEIVED
Thursday, July 3, 2025NOTICE OF ALLOWANCE CANCELLED
Tuesday, August 12, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, August 12, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED